Moreno A, Fortún J, Graus J, Rodriguez-Gandía MA, Quereda C, Pérez-Elías MJ, Nuño J, Wikman P, Moreno S, Bárcena R.

Severe rhabdomyolysis due to rosuvastatin in a liver transplant subject with human immunodeficiency virus and immunosuppressive therapy-related dyslipidemia.

LIVER TRANSPLANTATION 2011. 17(3): 331-333. Nº de citas: 8

[doi:10.1002/lt.22225]

Nieto A, Domínguez-Bernal G, Orden JA, De La Fuente R, Madrid-Elena N, Carrión J.

Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus syrian hamster model

VETERINARY RESEARCH 2011. 42: 39-39. Nº de citas: 63

[doi:10.1186/1297-9716-42-39]

Pérez-Molina JA, Díaz-Menéndez M, Gallego JI, Norman F, Monge-Maillo B, Ayala AP, López-Vélez R.

Evaluation of nitazoxanide for the treatment of disseminated cystic echinococcosis: report of five cases and literature review.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 2011. 84(2): 351-356. Nº de citas: 27

[doi:10.4269/ajtmh.2011.10-0513]

Ruiz-Camps I, Len O, MARTÍN DÁVILA, PILAR.

Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients

ANTIVIRAL THERAPY 2011. 16(7): 951-957. Nº de citas: 15

[doi:10.3851/IMP1858]

Yebra G, de Mulder M, Martín L, Pérez-Cachafeiro S, Rodríguez C, Labarga P, García F, Tural C, Jaén A, Navarro G, Holguín A.

Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS).

ANTIVIRAL RESEARCH 2011. 89(1): 19-25. Nº de citas: 19

[doi:10.1016/j.antiviral.2010.10.008]

Pérez-Molina JA, Suárez-Lozano I, Del Arco A, Teira R, Bachiller P, Pedrol E, Martínez-Alfaro E, Domingo P, Mariño A, Ribera E, Antela A, de Otero J, Navarro V, González-García J.

Late Initiation of HAART Among HIV-Infected Patients in Spain Is Frequent and Related to a Higher Rate of Virological Failure but not to Immigrant Status

HIV CLINICAL TRIALS 2011. 12(1): 1-8. Nº de citas: 10

[doi:10.1310/hct1201-1]

Pérez-Ayala A, Pérez-Molina JA, Norman F, Monge-Maillo B, Faro MV, López-Vélez R.

Gastro-intestinal Chagas disease in migrants to Spain: prevalence and methods for early diagnosis.

ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY 2011. 105(1): 25-29. Nº de citas: 27

[doi:10.1179/136485910X12851868780423]

Tural C, Solà R, Alvarez NP, Moltó J, Sánchez M, Zamora AM, Ornelas A, Laguno M, González J, von Wichmann MÁ, Téllez MJ, Paredes R, Clotet B.

Effect of an induction period of pegylated interferon-a2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study.

ANTIVIRAL THERAPY 2011. 16(6): 833-841. Nº de citas: 1

[doi:10.3851/IMP1837]

Parra J, Portilla J, Pulido F, Sánchez-de la Rosa R, Alonso-Villaverde C, Berenguer J, Blanco JL, Domingo P, Dronda F, Galera C, Gutiérrez F, Kindelán JM, Knobel H, Leal M, López-Aldeguer J, Mariño A, Miralles C, Moltó J, Ortega E, Oteo JA.

Clinical utility of maraviroc.

CLINICAL DRUG INVESTIGATION 2011. 31(8): 527-542. Nº de citas: 25

[doi:10.2165/11590700-000000000-00000]

Moreno S, González J, Lekander I, Martí B, Oyagüez I, Sánchez-de la Rosa R, Casado MA.

Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system.

Clinical therapeutics 2010. 32(13): 2232-2245. Nº de citas: 3

[doi:10.1016/S0149-2918(10)80026-8]

García-Leoni ME, Moreno S, García-Garrote F, Cercenado E.

Ventilator-associated pneumonia in long-term ventilator-assisted individuals

Spinal Cord 2010. 48(12): 876-880. Nº de citas: 10

[doi:10.1038/sc.2010.43]

Field V, Gautret P, Schlagenhauf P, Burchard GD, Caumes E, Jensenius M, Castelli F, Gkrania-Klotsas E, Weld L, Lopez-Velez R, de Vries P, von Sonnenburg F, Loutan L, Parola P.

Travel and migration associated infectious diseases morbidity in Europe, 2008.

BMC INFECTIOUS DISEASES 2010. 10: 330-330. Nº de citas: 104

[doi:10.1186/1471-2334-10-330]

Reekie J, Kosa C, Engsig F, Monforte Ad, Wiercinska-Drapalo A, Domingo P, Antunes F, Clumeck N, Kirk O, Lundgren JD, Mocroft A.

Relationship Between Current Level of Immunodeficiency and Non-Acquired Immunodeficiency Syndrome-Defining Malignancies

CANCER 2010. 116(22): 5306-5315. Nº de citas: 106

[doi:10.1002/cncr.25311]

Friis-Møller N, Thiébaut R, Reiss P, Weber R, Monforte AD, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O, Phillips A, Sabin CA, Lundgren JD, Law MG, DAD study group.

Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study

EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION 2010. 17(5): 491-501. Nº de citas: 262

[doi:10.1097/HJR.0b013e328336a150]

Mocroft A, Reiss P, Gasiorowski J, Ledergerber B, Kowalska J, Chiesi A, Gatell J, Rakhmanova A, Johnson M, Kirk O, Lundgren J.

Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2010. 55(2): 262-270. Nº de citas: 194

[doi:10.1097/QAI.0b013e3181e9be6b]

Fortun J, Martin-Davila P, Pascual J, Cervera C, Moreno A, Gavalda J, Aguado JM, Pereira P, Gurguí M, Carratala J, Fogueda M, Montejo M, Blasco F, Bou G, Torre-Cisneros J.

Immunosuppressive therapy and infection after kidney transplantation

TRANSPLANT INFECTIOUS DISEASE 2010. 12(5): 397-405. Nº de citas: 44

[doi:10.1111/j.1399-3062.2010.00526.x]

Pérez Molina JA, Rillo MM, Suárez-Lozano I, Casado Osorio JL, Cobo RT, González PR, Clotet EP, Jerez AH, Pedrol PD, Royuela A, Díaz EB, Esteban H, González-García J.

Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 Study

CURRENT HIV RESEARCH 2010. 8(7): 521-530. Nº de citas: 18

Blanco JR, Caro AM, Pérez-Cachafeiro S, Gutiérrez F, Iribarren JA, González-García J, Ferrando-Martínez S, Navarro G, Moreno S.

HIV Infection and Aging

AIDS REVIEWS 2010. 12(4): 218-230. Nº de citas: 42